An evaluation of the suitability of intravenous midazolam as an in vivo marker for hepatic cytochrome P4503A activity

Clin Pharmacol Ther. 2003 Mar;73(3):153-8. doi: 10.1067/mcp.2003.23.
No abstract available

Publication types

  • Evaluation Study

MeSH terms

  • Biomarkers
  • Cytochrome P-450 Enzyme System / metabolism*
  • Humans
  • Infusions, Intravenous
  • Liver / enzymology
  • Liver / metabolism*
  • Metabolic Clearance Rate
  • Midazolam / administration & dosage
  • Midazolam / blood
  • Midazolam / pharmacokinetics*
  • Models, Biological*

Substances

  • Biomarkers
  • Cytochrome P-450 Enzyme System
  • Midazolam